INTEGRA LIFESCIENCES HOLDINGS CORP Quarterly Costs and Expenses in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Integra Lifesciences Holdings Corp quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q2 2024.
  • Integra Lifesciences Holdings Corp Costs and Expenses for the quarter ending June 30, 2024 was $421M, a 14.2% increase year-over-year.
  • Integra Lifesciences Holdings Corp Costs and Expenses for the twelve months ending June 30, 2024 was $1.5B, a 10.2% increase year-over-year.
  • Integra Lifesciences Holdings Corp annual Costs and Expenses for 2023 was $1.43B, a 8.44% increase from 2022.
  • Integra Lifesciences Holdings Corp annual Costs and Expenses for 2022 was $1.32B, a 1.97% decline from 2021.
  • Integra Lifesciences Holdings Corp annual Costs and Expenses for 2021 was $1.35B, a 10.2% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.5B $421M +$52.4M +14.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $1.45B $365M +$20.4M +5.94% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.43B $361M +$30.8M +9.33% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $1.4B $356M +$35.7M +11.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-25
Q2 2023 $1.36B $369M +$30.8M +9.12% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 $1.33B $344M +$14M +4.23% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $1.32B $330M -$17.1M -4.93% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $1.34B $320M -$10.3M -3.11% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-25
Q2 2022 $1.35B $338M -$190K -0.06% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $1.35B $330M +$1.12M +0.34% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q4 2021 $1.35B $347M +$11.3M +3.36% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $1.33B $330M +$17.7M +5.67% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 $1.32B $338M +$93.6M +38.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 $1.22B $329M +$2.14M +0.65% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 $1.22B $336M -$23M -6.42% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 $1.24B $313M -$87M -21.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $1.33B $245M -$93.1M -27.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $1.42B $327M -$161K -0.05% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $1.42B $359M +$9.84M +2.82% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $1.41B $400M +$57.5M +16.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $1.36B $338M -$870K -0.26% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.36B $327M -$4.12M -1.24% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.36B $349M -$12.2M -3.37% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $1.37B $342M +$74M +27.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q2 2018 $1.3B $339M +$73.4M +27.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-25
Q1 2018 $1.23B $332M +$82.8M +33.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $1.14B $361M +$146M +68.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $997M $268M +$48M +21.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $949M $265M +$38.2M +16.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-26
Q1 2017 $911M $249M +$34M +15.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q4 2016 $877M $215M -$2.26M -1.04% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $879M $220M +$3.86M +1.79% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $875M $227M +$38.6M +20.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $837M $215M +$33.4M +18.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 $803M $217M +$94M +76.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $709M $216M +$36M +19.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $673M $188M -$30.6M -14% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $704M $181M -$25M -12.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-27
Q4 2014 $729M $123M +$105M +575% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $624M $180M -$64M -26.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $688M $219M +$19M +9.48% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-31
Q1 2014 $669M $206M +$7.48M +3.76% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q4 2013 $661M $18.2M -$178M -90.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $839M $244M +$54M +28.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $785M $200M +$7.84M +4.08% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $777M $199M +$20.1M +11.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $757M $196M +$100K +0.05% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $757M $190M +$6.45M +3.51% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-30
Q2 2012 $751M $192M +$6.82M +3.68% Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-08-02
Q1 2012 $744M $179M +$18.5M +11.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 $725M $196M +$25.8M +15.2% Oct 1, 2011 Dec 31, 2011 8-K 2014-06-20
Q3 2011 $699M $184M +$24.6M +15.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-24
Q2 2011 $675M $185M +$31.3M +20.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-31
Q1 2011 $643M $160M +$10.1M +6.74% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 $633M $170M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 $159M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $154M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $150M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.